Provided by Tiger Trade Technology Pte. Ltd.

Illumina

121.94
-2.4600-1.98%
Volume:38.34K
Turnover:4.69M
Market Cap:18.63B
PE:22.37
High:123.32
Open:123.00
Low:120.83
Close:124.40
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:1.01
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:6.84
PE(LYR):22.37

Loading ...

BRIEF-Illumina Partners Go Beyond The Genome, Driving Cancer Breakthroughs

Reuters
·
Feb 25

Illumina Announces New Multiomics Oncology Breakthroughs Using Spatial Transcriptomics, 5-Base Sequencing and Proteomics

Reuters
·
Feb 25

Illumina Partners Go Beyond the Genome, Driving Cancer Breakthroughs Using Spatial Transcriptomics, Epigenomics, and Proteomics

THOMSON REUTERS
·
Feb 25

Illumina Chief Legal Officer Scott M. Davies Reports Disposal of Common Shares

Reuters
·
Feb 25

Illumina announces launch of TruPath Genome

TIPRANKS
·
Feb 25

Illumina data show TruPath Genome boosts rare disease variant detection accuracy

Reuters
·
Feb 25

Illumina unveils 18-month NovaSeq X roadmap targeting Q70 quality and 35B reads output

Reuters
·
Feb 23

Law firms gird for tariff refund fight after Supreme Court ruling

Reuters
·
Feb 21

Illumina (ILMN) Gets a Hold from Canaccord Genuity

TIPRANKS
·
Feb 20

Illumina SVP and Chief People Officer Patricia Leckman Disposes of Common Shares

Reuters
·
Feb 19

Illumina to Webcast Fireside Chat at TD Cowen Health Care Conference

Reuters
·
Feb 18

Illumina: Weak Backlog Support and Rising Competitive Pressures Undermine 2026 Outlook, Justifying Sell Rating

TIPRANKS
·
Feb 17

Illumina posts FY net income of USD 0.85 billion, up 152 percent

Reuters
·
Feb 12

Illumina Director Makes Bold Insider Move With Fresh Stock Purchase

TIPRANKS
·
Feb 12

Illumina Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 10

Illumina Earnings Call Highlights Clinical Growth Momentum

TIPRANKS
·
Feb 07

Illumina Is Maintained at Neutral by JP Morgan

Dow Jones
·
Feb 07

Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL)

TIPRANKS
·
Feb 07

Illumina Down Over 9%, on Pace for Largest percent Decrease Since May 2022 -- Data Talk

Dow Jones
·
Feb 07

UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating

MT Newswires Live
·
Feb 06